ImmuneSpec
PrivateLast Round
Seed
Mar 24, 2023
Total Funding Raised
$1.3M
Company Overview
ImmuneSpec is a biotechnology company that provides high-sensitivity immunopeptidomics analysis services for the development of vaccines, immunotherapeutics, and personalized medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneSpec Comparables
Compare ImmuneSpec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pure MHC, LLC | 78% | |
| Bruker | 76% | |
| MS Bioworks | 74% | |
ImmuneSpec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 24, 2023 |
Key People
Founding team and executive leadership
ImmuneSpec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HERAN Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2023
$1.3M round led by HERAN Partners
ImmuneSpec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmuneSpec's valuation, stock price, and market status.